��������

Sabrinia Crouch possesses extensive experience in pharmacokinetics and drug metabolism and pharmacokinetics (DMPK) across various leading pharmaceutical companies. As a Senior Director at Vividion Therapeutics, Sabrinia Crouch has contributed to advancing DMPK strategies. Prior roles include serving as Associate Director and Principal Scientist at Takeda, and Principal Scientist in Discovery and Development PK/PD at Novo Nordisk. Sabrinia Crouch has also held significant leadership positions at Neurocrine Biosciences, including Executive Director and Director of Preclinical Pharmacokinetics, and has been recognized as a Discovery PK Expert at ATOM | Accelerating Therapeutics for Opportunities in Medicine.